TRH Receptor Antibodyfrom NSJ Bioreagents |
|
N1066-100UG | 100 ug: 356.15 EUR | |
Description: Thyrotropin-releasing hormone (TRH) is produced by tissues of the nervous system and to a lesser degree, pancreas, testis, adrenal gland and lymphoid organs. There are two types of TRH in rodents, TRH1 and 2, but only TRH1 in humans. In cells of the nervous system, it is a neurotransmitter, acting via its receptor, TRH receptor, to stimulate phosphoinositide-specific phospholipase C, which stimulates phosphatidylinositol hydrolysis to form inositol triphosphate. |
|
TRH Receptor Antibodyfrom NSJ Bioreagents |
|
N1066-25UG | 25 ug: 177.65 EUR | |
Description: Thyrotropin-releasing hormone (TRH) is produced by tissues of the nervous system and to a lesser degree, pancreas, testis, adrenal gland and lymphoid organs. There are two types of TRH in rodents, TRH1 and 2, but only TRH1 in humans. In cells of the nervous system, it is a neurotransmitter, acting via its receptor, TRH receptor, to stimulate phosphoinositide-specific phospholipase C, which stimulates phosphatidylinositol hydrolysis to form inositol triphosphate. |
|
Polyclonal TRH Receptor / TRHR Antibody (aa350-400)from Leading Biology |
|
AMM08318G | 0.05mg: 580.80 EUR | |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRH Receptor / TRHR (aa350-400). This antibody is tested and proven to work in the following applications: |
|
Polyclonal TRH Receptor / TRHR Antibody (C-Terminus)from Leading Biology |
|
AMM08319G | 0.05mg: 580.80 EUR | |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRH Receptor / TRHR (C-Terminus). This antibody is tested and proven to work in the following applications: |
|
Polyclonal TRH Receptor / TRHR Antibody (C-Terminus)from Leading Biology |
|
AMM08320G | 0.05mg: 580.80 EUR | |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRH Receptor / TRHR (C-Terminus). This antibody is tested and proven to work in the following applications: |
|
Polyclonal TRH Receptor / TRHR Antibody (C-Terminus)from Leading Biology |
|
AMM08330G | 0.05mg: 580.80 EUR | |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRH Receptor / TRHR (C-Terminus). This antibody is tested and proven to work in the following applications: |
|
Polyclonal TRH Receptor / TRHR Antibody (Cytoplasmic Domain)from Leading Biology |
|
AMM08331G | 0.05mg: 580.80 EUR | |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRH Receptor / TRHR (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|
TRH Receptor (TRHR) rabbit polyclonal antibody, Aff - Purifiedfrom Origene Technologies GmbH |
|
AP01441PU-N | 100 µg: Ask for price | |
TRH Receptor (TRHR) (350-400) rabbit polyclonal antibody, Aff - Purifiedfrom Origene Technologies GmbH |
|
AP08270PU-N | 50 µg: Ask for price | |
Thyrotropin-Releasing Hormone Receptor (TRH-R) (TRHR) Rabbit anti-Human Polyclonal Antibodyfrom GenWay Biotech |
|
GWB-883000 | 0.05 mg: Ask for price | |
Thyrotropin-Releasing Hormone Receptor (TRH-R) (TRHR) Rabbit anti-Human Polyclonal (aa350-400) Antibodyfrom GenWay Biotech |
|
GWB-A7167C | 0.05 mg: Ask for price | |
Anti- Thyrotropin Hormone Receptor (TRHR) Antibodyfrom GenWay Biotech |
|
GWB-97B33F | 0.05 mg: Ask for price | |
TRH Antibodyfrom EnoGene |
|
E311829 | 200ul: 275.00 EUR | |
Description: Available in various conjugation types. |
|
TRH antibodyfrom Fitzgerald |
|
70R-10567 | 50 ug: 467.00 EUR | |
Description: Affinity purified rabbit polyclonal TRH antibody |
|
TRH Antibodyfrom GenWay Biotech |
|
GWB-MX439G | 50ug: Ask for price | |
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3354-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3354-20UG | 20 ug: 186.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3354SAF-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3355-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3355-20UG | 20 ug: 186.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3355SAF-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3356-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85 kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin (LHR/CGR). Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3356-20UG | 20 ug: 186.15 EUR | |
Description: Recognizes a protein of 78-85 kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin (LHR/CGR). Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
hCG Receptor / LH Receptor Antibodyfrom NSJ Bioreagents |
|
V3356SAF-100UG | 100 ug: 424.15 EUR | |
Description: Recognizes a protein of 78-85 kDa, which is identified as the receptor for Luteinizing hormone / Choriogonadotropin (LHR/CGR). Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. |
|
APOE Receptor (LDL Receptor) Antibodyfrom Abbexa |
|
abx022339-005mg | 0.05 mg: 1195.20 EUR | |
MC2 Receptor Antibody / ACTH Receptorfrom NSJ Bioreagents |
|
R32754 | 100ug: 356.15 EUR | |
Description: Melanocortin-2 receptor (MC2R), also known as ACTH receptor (ACTHR), is a member of the G protein-coupled receptor family. This gene is mapped to 18p11.2. MC2R is selectively activated by adrenocorticotropic hormone, whereas the other four melanocortin receptors recognize a variety of melanocortin ligands. Mutations in MC2R can result in familial glucocorticoid deficiency. Alternate transcript variants have been found for this gene. |
|
GnRH Receptor Antibody / LHCG Receptorfrom NSJ Bioreagents |
|
RQ6491 | 100ug: 356.15 EUR | |
Description: The luteinizing hormone/choriogonadotropin receptor is a member of a subfamily of G protein-coupled receptors (GPCR) characterized by the presence of a large N-terminal extracellular domain containing several leucine-rich repeats (LRR). This glycoprotein hormone receptor family has been named the LRR-containing GPCR (LGR) family. The LHCGR gene contains 11 exons and spans approximately 80 kb and it is mapped to chromosome 2p21. In the ovary, theca, stromal, late-stage (luteinizing) granulosa, and luteal cells contain LHCGR. In the testes, Leydig cells contain LHCRG. |
|
GnRH Receptor Antibody / LHCG Receptorfrom NSJ Bioreagents |
|
V7814-100UG | 100 ug: 349.30 EUR | |
Description: Recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations. |
|
GnRH Receptor Antibody / LHCG Receptorfrom NSJ Bioreagents |
|
V7814-20UG | 20 ug: 153.30 EUR | |
Description: Recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations. |
|
GnRH Receptor Antibody / LHCG Receptorfrom NSJ Bioreagents |
|
V7814SAF-100UG | 100 ug: 349.30 EUR | |
Description: Recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations. |
|
Oxytocin Receptor (Oxytocin Receptor) Antibodyfrom Abbexa |
|
abx431481-200ul | 200 ul: 343.20 EUR | |
Oxytocin Receptor (Oxytocin Receptor) Antibodyfrom Abbexa |
|
abx236056-100ug | 100 ug: 661.20 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
20-abx333755 | [ 100 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 20 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
20-abx329896 | [ 100 ug: Ask for price ] [ 50 ug: Ask for price ] | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx030262-400ul | 400 ul: 627.60 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx030262-80l | 80 µl: 343.20 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx030262-400l | 400 µl: 518.75 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx329896-100g | 100 µg: Ask for price | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx329896-20g | 20 µg: 187.50 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx329896-50g | 50 µg: 250.00 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx333755-100g | 100 µg: 362.50 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx333755-20g | 20 µg: 162.50 EUR | |
Thyrotropin-Releasing Hormone Receptor (TRHR) Antibodyfrom Abbexa |
|
abx333755-50g | 50 µg: 250.00 EUR | |
IGF-I Receptor/Insulin Receptor Antibodyfrom EnoGene |
|
E11-184697 | 100ug/100ul: 225.00 EUR | |
Description: Available in various conjugation types. |
|
anti-IgE receptor antibody/ Rat anti- IgE receptor antibody ELISfrom Lifescience Market |
|
ELA-E0378r | 96 Tests: 1063.20 EUR | |
IP Receptor Antibodyfrom EnoGene |
|
E38PA4794 | 100ul: 225.00 EUR | |
Description: Available in various conjugation types. |
|
B5 Receptor Antibodyfrom Abbexa |
|
abx430923-200ul | 200 ul: 460.80 EUR | |
IP Receptor Antibodyfrom Abbexa |
|
20-abx133296 | [ 100 ul: Ask for price ] [ 200 ul: Ask for price ] [ 30 ul: Ask for price ] | |
B5 Receptor Antibodyfrom Abbexa |
|
abx430923-200l | 200 µl: 387.50 EUR | |
AFP Receptor antibodyfrom Fitzgerald |
|
10-7877 | 1 mg: 590.40 EUR | |
Description: Mouse monoclonal AFP Receptor antibody |
|
LDL Receptor antibodyfrom Fitzgerald |
|
10R-L104a | 50 ug: 546.00 EUR | |
Description: Mouse monoclonal LDL Receptor antibody |
|
LDL Receptor antibodyfrom Fitzgerald |
|
20R-LR002 | 250 ul: 583.00 EUR | |
Description: Rabbit polyclonal LDL Receptor antibody |
|
TNF Receptor Antibodyfrom SAB |
|
33527 | 100ul: 319.00 EUR | |
MC4 Receptor Antibodyfrom Biovision |
|
3936-100 | each: 379.20 EUR | |
MC4 Receptor Antibodyfrom Biovision |
|
3936-30T | each: 175.20 EUR | |
LDL Receptor Antibodyfrom SAB |
|
48760 | 100ul: 499.00 EUR | |
LDL Receptor Antibodyfrom SAB |
|
48760-100ul | 100ul: 399.60 EUR | |
LDL Receptor Antibodyfrom SAB |
|
48760-50ul | 50ul: 286.80 EUR | |
IP3 Receptor Antibodyfrom EnoGene |
|
E19-3000-1 | 50ug/50ul: 145.00 EUR | |
Description: Available in various conjugation types. |
|
IP3 Receptor Antibodyfrom EnoGene |
|
E19-3000-2 | 100ug/100ul: 225.00 EUR | |
Description: Available in various conjugation types. |
|
EGF Receptor Antibodyfrom NSJ Bioreagents |
|
F49183-0.08ML | 0.08 ml: 140.25 EUR | |
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. |
|
EGF Receptor Antibodyfrom NSJ Bioreagents |
|
F50598-0.4ML | 0.4 ml: 322.15 EUR | |
Description: The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer. |
|
FGF Receptor Antibodyfrom NSJ Bioreagents |
|
F50614-0.4ML | 0.4 ml: 322.15 EUR | |
Description: FGFR1 is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene can lead to Pfeiffer syndrome and Jackson-Weiss syndrome. |
|
MC4 Receptor Antibodyfrom EnoGene |
|
E38PA1725 | 100ul: 225.00 EUR | |
Description: Available in various conjugation types. |
|
IP3 Receptor Antibodyfrom EnoGene |
|
E90863 | 100ul: 255.00 EUR | |
Description: Available in various conjugation types. |
|
EGF Receptor Antibodyfrom NSJ Bioreagents |
|
F40405-0.08ML | 0.08 ml: 140.25 EUR | |
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. |
|
EGF Receptor Antibodyfrom NSJ Bioreagents |
|
F40405-0.4ML | 0.4 ml: 330.65 EUR | |
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. |
|
EGF Receptor Antibodyfrom NSJ Bioreagents |
|
F40415-0.08ML | 0.08 ml: 140.25 EUR | |
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. |
|
EGF Receptor Antibodyfrom GenWay Biotech |
|
GWB-2B2E2D | 0.2 mg: Ask for price | |
NGF receptor Antibodyfrom GenWay Biotech |
|
GWB-2EFCCD | 0.1 ml: Ask for price | |
EGF Receptor Antibodyfrom GenWay Biotech |
|
GWB-2F9F55 | 0.05 mg: Ask for price | |
HGF receptor Antibodyfrom GenWay Biotech |
|
GWB-3AD21B | 0.025 mg: Ask for price | |
HGF receptor Antibodyfrom GenWay Biotech |
|
GWB-3D99F3 | 0.025 mg: Ask for price | |
TSH receptor Antibodyfrom GenWay Biotech |
|
GWB-469FEA | 0.1 mg: Ask for price | |
IP3 Receptor Antibodyfrom Affbiotech |
|
DF3000 | 200ul: 420.00 EUR | |
IP3 Receptor Antibodyfrom Affinity Biosciences |
|
DF3000-100ul | 100ul: 280.00 EUR | |
IP3 Receptor Antibodyfrom Affinity Biosciences |
|
DF3000-200ul | 200ul: 350.00 EUR | |
PAF Receptor Antibodyfrom Affbiotech |
|
DF13866 | 100ul: 420.00 EUR | |
PAF Receptor Antibodyfrom Affinity Biosciences |
|
DF13866-100ul | 100ul: 280.00 EUR | |
PAF Receptor Antibodyfrom Affinity Biosciences |
|
DF13866-200ul | 200ul: 350.00 EUR | |
GIP Receptor Antibodyfrom EnoGene |
|
E38PA5285 | 100ul: 225.00 EUR | |
Description: Available in various conjugation types. |
|
EP1 receptor Antibodyfrom Abbexa |
|
abx430938-200ul | 200 ul: 460.80 EUR | |
IP3 Receptor Antibodyfrom Affbiotech |
|
AF6591 | 100ul: 420.00 EUR | |
IP3 Receptor Antibodyfrom Affinity Biosciences |
|
AF6591-100ul | 100ul: 280.00 EUR | |
IP3 Receptor Antibodyfrom Affinity Biosciences |
|
AF6591-200ul | 200ul: 350.00 EUR | |
IP3 Receptor Antibodyfrom Affbiotech |
|
AF6592 | 100ul: 420.00 EUR | |
IP3 Receptor Antibodyfrom SAB |
|
49582 | 100ul: 499.00 EUR | |
IP3 Receptor Antibodyfrom SAB |
|
49582-100ul | 100ul: 399.60 EUR |